External Factors Affecting Protein Aggregation

Aggregation of Therapeutic Proteins

Volumn , Issue , 2010, Pages 119-204

  Wang, Wei ^a   Li, Ning ^a   Speaker, Stan ^a  

^a PFIZER INC   (United States)

Author keywords

External factors affecting protein aggregation; Protein concentration effect on protein aggregation; Solution conditions and composition on protein aggregation

Indexed keywords

EID: 84864421230     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470769829.ch4     Document Type: Chapter

References (427)

1. Wang W. 2005. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289 (1-2): 1-30.
2. Townsend MW, Byron PR, DeLuca PP. 1990. The effects of formulation additives on the degradation of freeze-dried ribonuclease A. Pharm Res 7 (10): 1086-1091.
3. Cleland JL, Wang DI. 1990. Refolding and aggregation of bovine carbonic anhydrase B: Quasi-elastic light scattering analysis. Biochemistry 29 (50): 11072-11078.
4. Runkel L, Meier W, Pepinsky RB, Karpusas M, Whitty A, Kimball K, Brickelmaier M, Muldowney C, Jones W, Goelz SE. 1998. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta). Pharm Res 15 (4): 641-649.
5. Nesta DP, Elliott JS, Warr JP. 2000. Supercritical fluid precipitation of recombinant human immunoglobulin from aqueous solutions. Biotechnol Bioeng 67 (4): 457-464.
6. Wang W, Kelner DN. 2003. Correlation of rFVIII inactivation with aggregation in solution. Pharm Res 20 (4): 693-700.
7. Clark AC. 2008. Protein folding: Are we there yet? Arch Biochem Biophys 469 (1): 1-3.
8. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJ, Middaugh CR, Winter G, Fan YX, Kirshner S, Verthelyi D, Kozlowski S, Clouse KA, Swann PG, Rosenberg A, Cherney B. 2008. Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise product quality. J Pharm Sci. doi: 10.1002/jps.21530.
9. Fink AL. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 3 (1): R9-R23.
10. Fields G, Alonso D, Stiger D, Dill KA. 1992. Theory for the aggregation of proteins and copolymers. J Phys Chem 96: 3974-3981.
11. Murphy KP, Bhakuni V, Xie D, Freire E. 1992. Molecular basis of co-operativity in protein folding. III. Structural identification of folding units and folding intermediates. J Mol Biol 227 (1): 293-306.
12. Kendrick BS, Carpenter JF, Cleland JL, Randolph TW. 1998. A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. Proc Natl Acad Sci U S A 95 (24): 14142-14146.
13. Damodaran S, Song KB. 1988. Kinetics of adsorption of proteins at interfaces: Role of protein conformation in diffusional adsorption. Biochim Biophys Acta 954 (3): 253-264.
14. Uversky VN, Karnoup AS, Khurana R, Segel DJ, Doniach S, Fink AL. 1999. Association of partially-folded intermediates of staphylococcal nuclease induces structure and stability. Protein Sci 8 (1): 161-173.
15. Espargaro A, Castillo V, de Groot NS, Ventura S. 2008. The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: The SH3 case. J Mol Biol 378(5): 1116-1131.
16. Zhang L, Lu D, Liu Z. 2008. How native proteins aggregate in solution: A dynamic Monte Carlo simulation. Biophys Chem 133 (1-3): 71-80.
17. Weiss WFt, Young TM, Roberts CJ. 2008. Principles, approaches, and challenges for predicting protein aggregation rates and shelf life. J Pharm Sci. doi: 10.1002/ jps.21521.
18. Raso SW, Abel J, Barnes JM, Maloney KM, Pipes G, Treuheit MJ, King J, Brems DN. 2005. Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state. Protein Sci 14 (9): 2246-2257.
19. Safar J, Roller PP, Gajdusek DC, Gibbs JCJ. 1994. Scrapie amyloid (prion) protien has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 33: 8375-8383.
20. Cleland JL, Wang DI. 1992. Transient association of the first intermediate during the refolding of bovine carbonic anhydrase B. Biotechnol Prog 8 (2): 97-103.
21. Hammarstrom P, Persson M, Freskgard PO, Martensson LG, Andersson D, Jonsson BH, Carlsson U. 1999. Structural mapping of an aggregation nucleation site in a molten globule intermediate. J Biol Chem 274 (46): 32897-32903.
22. Bam NB, Cleland JL, Randolph TW. 1996. Molten globule intermediate of recombinant human growth hormone: Stabilization with surfactants. Biotechnol Prog 12 (6): 801-809.
23. Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E. 1997. Toward understanding insulin fibrillation. J Pharm Sci 86 (5): 517-525.
24. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CC, Pepys MB. 1997. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385 (6619): 787-793.
25. Speed MA, King J, Wang DIC. 1997. Polymerization mechanism of polypeptide chain aggregation. Biotechnol Bioeng 54: 333-343.
26. Schuler B, Rachel R, Seckler R. 1999. Formation of fibrous aggregates from a non-native intermediate: The isolated P22 tailspike beta-helix domain. J Biol Chem 274 (26): 18589-18596.
27. Teschke CM. 1999. Aggregation and assembly of phage P22 temperature-sensitive coat protein mutants in vitro mimic the in vivo phenotype. Biochemistry 38 (10): 2873-2881.
28. Chi EY, Krishnan S, Kendrick BS, Chang BS, Carpenter JF, Randolph TW. 2003. Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor. Protein Sci 12 (5): 903-913.
29. Militello V, Casarino C, Emanuele A, Giostra A, Pullara F, Leone M. 2004. Aggregation kinetics of bovine serum albumin studied by FTIR spectroscopy and light scattering. Biophys Chem 107 (2): 175-187.
30. Vetri V, Militello V. 2005. Thermal induced conformational changes involved in the aggregation pathways of beta-lactoglobulin. Biophys Chem 113 (1): 83-91.
31. Katayama DS, Nayar R, Chou DK, Valente JJ, Cooper J, Henry CS, Vander Velde DG, Villarete L, Liu CP, Manning MC. 2006. Effect of buffer species on the thermally induced aggregation of interferon-tau. J Pharm Sci 95 (6): 1212-1226.
32. Ecroyd H, Carver JA. 2008. The effect of small molecules in modulating the chaperone activity of alpha B-crystallin against ordered and disordered protein aggregation. FEBS J 275 (5): 935-947.
33. Necula M, Kayed R, Milton S, Glabe CG. 2007. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282 (14): 10311-10324.
34. Liu J, Nguyen MD, Andya JD, Shire SJ. 2005. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. J Pharm Sci 94 (9): 1928-1940.
35. Alford JR, Kendrick BS, Carpenter JF, Randolph TW. 2008. High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics. J Pharm Sci 97 (8): 3005-3021.
36. Kanai S, Liu J, Patapoff TW, Shire SJ. 2008. Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity. J Pharm Sci. doi:10.1002/jps.21322.
37. Saluja A, Kalonia DS. 2008. Nature and consequences of protein-protein interactions in high protein concentration solutions. Int J Pharm 358 (1-2): 1-15.
38. Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20 (9): 1325-1336.
39. Richards JP, Stickelmeyer MP, Flora DB, Chance RE, Frank BH, DeFelippis MR. 1998. Self-association properties of monomeric insulin analogs under formulation conditions. Pharm Res 15 (9): 1434-1441.
40. Bajaj H, Sharma VK, Badkar A, Zeng D, Nema S, Kalonia DS. 2006. Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution. Pharm Res 23 (6): 1382-1394.
41. Broersen K, Weijers M, de Groot J, Hamer RJ, de Jongh HHJ. 2007. Effect of protein charge on the generation of aggregation-prone conformers. Biomacromolecules 8 (5): 1648-1656.
42. Krebs MR, Devlin GL, Donald AM. 2007. Protein particulates: Another generic form of protein aggregation? Biophys J 92 (4): 1336-1342.
43. Wang YJ, Shahrokh Z, Vemuri S, Eberlein G, Beylin I, Busch M. 1996. Characterization, stability, and formulations of basic fibroblast growth factor. Pharm Biotechnol 9: 141-180.
44. Shahrokh Z, Eberlein G, Buckley D, Paranandi MV, Aswad DW, Stratton P, Mischak R, Wang YJ. 1994. Major degradation products of basic fibroblast growth factor: Detection of succinimide and iso-aspartate in place of aspartate. Pharm Res 11 (7): 936-944.
45. Yoshioka S, Aso Y, Izutsu K, Terao T. 1993. Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state. Pharm Res 10 (5): 687-691.
46. Jordan GM, Yoshioka S, Terao T. 1994. The aggregation of bovine serum albumin in solution and in the solid state. J Pharm Pharmacol 46 (3): 182-185.
47. Livney YD, Dalgleish DG. 2004. Specificity of disulfide bond formation during thermal aggregation in solutions of beta-lactoglobulin b and kappa-casein A. J Agric Food Chem 52 (17): 5527-5532.
48. Livney YD, Verespej E, Dalgleish DG. 2003. Steric effects governing disulfide bond interchange during thermal aggregation in solutions of beta-lactoglobulin B and alpha-lactalbumin. J Agric Food Chem 51 (27): 8098-8106.
49. Cabra V, Vazquez-Contreras E, Moreno A, Arreguin-Espinosa R. 2008. The effect of sulfhydryl groups and disulphide linkage in the thermal aggregation of Z19 alpha-zein. Biochim Biophys Acta 1784 (7-8): 1028-1036.
50. Costantino HR, Langer R, Klibanov AM. 1994. Moisture-induced aggregation of lyophilized insulin. Pharm Res 11 (1): 21-29.
51. Malencik DA, Anderson SR. 2003. Dityrosine as a product of oxidative stress and fluorescent probe. Amino Acids 25 (3-4): 233-247.
52. Schwendeman SP, Costantino HR, Gupta RK, Siber GR, Klibanov AM, Langer R. 1995. Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation. Proc Natl Acad Sci U S A 92 (24): 11234-11238.
53. Malencik DA, Anderson SR. 2003. Dityrosine as a product of oxidative stress and fluorescent probe. Amino Acids 25 (3-4): 233-247.
54. Khossravi M, Shire SJ, Borchardt RT. 2000. Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry 39 (19): 5876-5885.
55. Liang JN, Rossi MT. 1990. In vitro non-enzymatic glycation and formation of browning products in the bovine lens alpha-crystallin. Exp Eye Res 50 (4): 367-371.
56. Zarina S, Zhao HR, Abraham EC. 2000. Advanced glycation end products in human senile and diabetic cataractous lenses. Mol Cell Biochem 210 (1-2): 29-34.
57. Hu D, Qin Z, Xue B, Fink AL, Uversky VN. 2008. Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN. Biochemistry (Mosc) 47 (33): 8665-8677.
58. Li S, Nguyen TH, Schoneich C, Borchardt RT. 1995. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry 34 (17): 5762-5772.
59. Hawkins CL, Davies MJ. 2005. The role of aromatic amino acid oxidation, protein unfolding, and aggregation in the hypobromous acid-induced inactivation of trypsin inhibitor and lysozyme. Chem Res Toxicol 18 (11): 1669-1677.
60. Gu LC, Erdos EA, Chiang HS, Calderwood T, Tsai K, Visor GC, Duffy J, Hsu WC, Foster LC. 1991. Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: Analytical methods, kinetics, products, and solution formulation implications. Pharm Res 8 (4): 485-490.
61. Van Buren N, Rehder D, Gadgil H, Matsumura M, Jacob J. 2008. Elucidation of two major aggregation pathways in an IgG2 antibody. J Pharm Sci. doi: 10.1002/ jps.21514.
62. Takata T, Oxford JT, Demeler B, Lampi KJ. 2008. Deamidation destabilizes and triggers aggregation of a lens protein, {beta}A3-crystallin. Protein Sci. doi:10.1110/ ps.035410.108.
63. Flaugh SL, Mills IA, King J. 2006. Glutamine deamidation destabilizes human gammaD-crystallin and lowers the kinetic barrier to unfolding. J Biol Chem 281 (41): 30782-30793.
64. von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E. 2001. Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276 (51): 48165-48174.
65. Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ. 2004. Hsp70 reduces alpha-synuclein aggregation and toxicity. J Biol Chem 279 (24): 25497-25502.
66. Mizuguchi M, Hayashi A, Takeuchi M, Dobashi M, Mori Y, Shinoda H, Aizawa T, Demura M, Kawano K. 2008. Unfolding and aggregation of transthyretin by the truncation of 50 N-terminal amino acids. Proteins 72 (1): 261-269.
67. Hoiberg-Nielsen R, Fuglsang CC, Arleth L, Westh P. 2006. Interrelationships of glycosylation and aggregation kinetics for Peniophora lycii phytase. Biochemistry (Mosc) 45 (15): 5057-5066.
68. Baynes BM, Wang DI, Trout BL. 2005. Role of arginine in the stabilization of proteins against aggregation. Biochemistry 44 (12): 4919-4925.
69. Gsponer J, Vendruscolo M. 2006. Theoretical approaches to protein aggregation. Protein Pept Lett 13 (3): 287-293.
70. Jarrett JT, Lansbury PT Jr. 1993. Amyoid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31: 12345-12352.
71. Finke JM, Roy M, Zimm BH, Jennings PA. 2000. Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1beta. Biochemistry 39 (3): 575-583.
72. Lomakin A, Teplow DB, Kirschner DA, Benedek GB. 1997. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A 94: 7942-7947.
73. Szabo Z, Klement E, Jost K, Zarandi M, Soos K, Penke B. 1999. An FT-IR study of the beta-amyloid conformation: standardization of aggregation grade. Biochem Biophys Res Commun 265 (2): 297-300.
74. Weiss WFt, Hodgdon TK, Kaler EW, Lenhoff AM, Roberts CJ. 2007. Nonnative protein polymers: Structure, morphology, and relation to nucleation and growth. Biophys J 93 (12): 4392-4403.
75. Boeris V, Spelzini D, Salgado JP, Pico G, Romanini D, Farruggia B. 2008. Chymotrypsin-poly vinyl sulfonate interaction studied by dynamic light scattering and turbidimetric approaches. Biochim Biophys Acta 1780 (9): 1032-1037.
76. Won CM, Molnar TE, McKean RE, Spenlehauer GA. 1998. Stabilizers against heat-induced aggregation of RPR 114849, an acidic fibroblast growth factor (AFGF). Int J Pharm 167: 25-36.
77. Raibekas AA, Bures EJ, Siska CC, Kohno T, Latypov RF, Kerwin BA. 2005. Anion binding and controlled aggregation of human interleukin-1 receptor antagonist. Biochemistry (Mosc) 44 (29): 9871-9879.
78. Rezaei-Ghaleh N, Ramshini H, Ebrahim HA, Moosavi MAA, Nemat GM. 2008. Thermal aggregation of alpha-chymotrypsin: Role of hydrophobic and electrostatic interactions. Biophys Chem 132 (1): 23-32.
79. De Young LR, Dill KA, Fink AL. 1993. Aggregation and denaturation of apomyoglobin in aqueous urea solutions. Biochemistry 32 (15): 3877-3886.
80. Wang K, Kurganov BI. 2003. Kinetics of heat-and acidification-induced aggregation of firefly luciferase. Biophys Chem 106 (2): 97-109.
81. Giese A, Bader B, Bieschke J, Schaffar G, Odoy S, Kahle PJ, Haass C, Kretzschmar H. 2005. Single particle detection and characterization of synuclein co-aggregation. Biochem Biophys Res Commun 333 (4): 1202-1210.
82. Cellmer T, Douma R, Huebner A, Prausnitz J, Blanch H. 2007. Kinetic studies of protein L aggregation and disaggregation. Biophys Chem 125 (2-3): 350-359.
83. Sun Y, Hayakawa S. 2002. Heat-induced gels of egg white/ovalbumins from five avian species: Thermal aggregation, molecular forces involved, and rheological properties. J Agric Food Chem 50 (6): 1636-1642.
84. Sluzky V, Tamada JA, Klibanov AM, Langer R. 1991. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A 88: 9377-9381.
85. Sluzky V, Klibanov AM, Langer R. 1992. Mechanism of insulin aggregation and stabilization in agitated aqueous solutions. Biotechnol Bioeng 40: 895-903.
86. Darrington RT, Anderson BD. 1995. Evidence for a common intermediate in insulin deamidation and covalent dimer formation: Effects of pH and aniline trapping in dilute acidic solutions. J Pharm Sci 84: 275-282.
87. Costantino HR, Langer R, Klibanov AM. 1994. Moisture-induced aggregation of lyophilized insulin. Pharm Res 11: 21-29.
88. Brange J, Havelund S, Hougaard P. 1992. Chemical stability of insulin. 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. Pharm Res 9 (6): 727-734.
89. Shahrokh Z, Stratton PR, Eberlein GA, Wang YJ. 1994. Approaches to analysis of aggregates and demonstrating mass balance in pharmaceutical protein (basic fibroblast growth factor) formulations. J Pharm Sci 83 (12): 1645-1650.
90. Rousseau F, Schymkowitz J, Serrano L. 2006. Protein aggregation and amyloidosis: Confusion of the kinds? Curr Opin Struct Biol 16 (1): 118-126.
91. Wikipedia. 2009. Available at http://enwikipediaorg/wiki/Thermodynamic_ temperature.
92. Macchioni A, Ciancaleoni G, Zuccaccia C, Zuccaccia D. 2008. Determining accurate molecular sizes in solution through NMR diffusion spectroscopy. Chem Soc Rev 37 (3): 479-489.
93. Dill KA. 1990. Dominant forces in protein folding. Biochemistry 29 (31): 7133-7155.
94. Jaenicke R. 2000. Stability and stabilization of globular proteins in solution. J Biotechnol 79 (3): 193-203.
95. Pace CN, Shirley BA, McNutt M, Gajiwala K. 1996. Forces contributing to the conformational stability of proteins. FASEB J 10 (1): 75-83.
96. Chen Y, Ding F, Nie H, Serohijos AW, Sharma S, Wilcox KC, Yin S, Dokholyan NV. 2008. Protein folding: Then and now. Arch Biochem Biophys 469 (1): 4-19.
97. Talla-Singh D, Stites WE. 2008. Refinement of noncalorimetric determination of the change in heat capacity, DeltaC(p), of protein unfolding and validation across a wide temperature range. Proteins 71 (4): 1607-1616.
98. Rees DC, Robertson AD. 2001. Some thermodynamic implications for the thermostability of proteins. Protein Sci 10 (6): 1187-1194.
99. Jaenicke R. 1991. Protein stability and molecular adaptation to extreme conditions. Eur J Biochem 202 (3): 715-728.
100. Giger K, Vanam RP, Seyrek E, Dubin PL. 2008. Suppression of insulin aggregation by heparin. Biomacromolecules 9 (9): 2338-2344.
101. Demeule B, Lawrence MJ, Drake AF, Gurny R, Arvinte T. 2007. Characterization of protein aggregation: The case of a therapeutic immunoglobulin. Biochim Biophys Acta 1774 (1): 146-153.
102. Kato A, Takagi T. 1988. Formation of intermolecular b-sheet structure during heat denaturation of ovalbumin. J Agric Food Chem 36: 1156-1159.
103. Fabian H, Falber K, Gast K, Reinstadler D, Rogov VV, Naumann D, Zamyatkin DF, Filimonov VV. 1999. Secondary structure and oligomerization behavior of equilibrium unfolding intermediates of the lambda cro repressor. Biochemistry 38 (17): 5633-5642.
104. Boctor AM, Mehta SC. 1992. Enhancement of the stability of thrombin by polyols: Microcalorimetric studies. J Pharm Pharmacol 44 (7): 600-603.
105. Charman SA, Mason KL, Charman WN. 1993. Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone. Pharm Res 10 (7): 954-962.
106. Narhi LO, Philo JS, Sun B, Chang BS, Arakawa T. 1999. Reversibility of heat-induced denaturation of the recombinant human megakaryocyte growth and development factor. Pharm Res 16 (6): 799-807.
107. Calamai M, Canale C, Relini A, Stefani M, Chiti F, Dobson CM. 2005. Reversal of protein aggregation provides evidence for multiple aggregated States. J Mol Biol 346 (2): 603-616.
108. Krishnan S, Chi EY, Webb JN, Chang BS, Shan D, Goldenberg M, Manning MC, Randolph TW, Carpenter JF. 2002. Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic inhibition. Biochemistry 41 (20): 6422-6431.
109. Chen BL, Arakawa T, Morris CF, Kenney WC, Wells CM, Pitt CG. 1994. Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization. Pharm Res 11 (11): 1581-1587.
110. Brange J, Langkjaer L. 1997. Insulin formulation and delivery. Pharm Biotechnol 10: 343-409.
111. Hall D, Minton AP. 2005. Turbidity as a probe of tubulin polymerization kinetics: A theoretical and experimental re-examination. Anal Biochem 345 (2): 198-213.
112. Chi EY, Weickmann J, Carpenter JF, Manning MC, Randolph TW. 2005. Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. J Pharm Sci 94 (2): 256-274.
113. Chi EY, Kendrick BS, Carpenter JF, Randolph TW. 2005. Population balance modeling of aggregation kinetics of recombinant human interleukin-1 receptor antagonist. J Pharm Sci 94 (12): 2735-2748.
114. Roy S, Katayama D, Dong A, Kerwin BA, Randolph TW, Carpenter JF. 2006. Temperature dependence of benzyl alcohol-and 8-anilinonaphthalene-1-sulfonate-induced aggregation of recombinant human interleukin-1 receptor antagonist. Biochemistry (Mosc) 45 (12): 3898-3911.
115. Chen B, Bautista R, Yu K, Zapata GA, Chamow SM. 2003. Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms. Pharm Res 20 (12): 1952-1960.
116. Jiskoot W, Beuvery EC, de Koning AAM, Herron JN, Crommelin DJA. 1990. Analytical approaches to the study of monoclonal antibody stability. Pharm Res 7: 1234-1241.
117. Oliva A, SantoveZa A, Llabres M, Rarina JB. 1999. Stability study of human serum albumin pharmaceutical preparations. J Pharm Pharmacol 51: 385-392.
118. Soenderkaer S, Carpenter JF, Van De Weert M, Hansen LL, Flink J, Frokjaer S. 2004. Effects of sucrose on rFVIIa aggregation and methionine oxidation. Eur J Pharm Sci 21 (5): 597-606.
119. Zlateva T, Boteva R, Salvato B, Tsanev R. 1999. Factors affecting the dissociation and aggregation of human interferon gamma. Int J Biol Macromol 26 (5): 357-362.
120. Vilasi S, Iannuzzi C, Portaccio M, Irace G, Sirangelo I. 2008. Effect of trehalose on W7FW14F apomyoglobin and insulin fibrillization: New insight into inhibition activity. Biochemistry (Mosc) 47 (6): 1789-1796.
121. McGuffey MK, Epting KL, Kelly RM, Foegeding EA. 2005. Denaturation and aggregation of three alpha-lactalbumin preparations at neutral pH. J Agric Food Chem 53 (8): 3182-3190.
122. Yan YB, Wang Q, He HW, Zhou HM. 2004. Protein thermal aggregation involves distinct regions: Sequential events in the heat-induced unfolding and aggregation of hemoglobin. Biophys J 86 (3): 1682-1690.
123. Gaikwad SM, Khan MI. 2003. pH-dependent aggregation of oligomeric Artocarpus hirsuta lectin on thermal denaturation. Biochem Biophys Res Commun 311 (2): 254-257.
124. Barzegar A, Moosavi-Movahedi AA, Rezaei-Zarchi S, Saboury AA, Ganjali MR, Norouzi P, Hakimelahi GH, Tsai FY. 2008. The mechanisms underlying the effect 186 AGGREGATION OF THERAPEUTIC PROTEINS of alpha-cyclodextrin on the aggregation and stability of alcohol dehydrogenase. Biotechnol Appl Biochem 49 (Pt 3): 203-211.
125. Benjwal S, Verma S, Roehm KH, Gursky O. 2006. Monitoring protein aggregation during thermal unfolding in circular dichroism experiments. Protein Sci 15 (3): 635-639.
126. Golub NV, Markossian KA, Kasilovich NV, Sholukh MV, Orlov VN, Kurganov BI. 2008. Thermal inactivation, denaturation and aggregation of mitochondrial aspartate aminotransferase. Biophys Chem 135 (1-3): 125-131.
127. Petersen SB, Jonson V, Fojan P, Wimmer R, Pedersen S. 2004. Sorbitol prevents the self-aggregation of unfolded lysozyme leading to an up to 13°C stabilisation of the folded form. J Biotechnol 114 (3): 269-278.
128. Derrick T, Grillo AO, Vitharana SN, Jones L, Rexroad J, Shah A, Perkins M, Spitznagel TM, Middaugh CR. 2007. Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2). J Pharm Sci 96 (4): 761-776.
129. Arnaudov LN, de Vries R. 2005. Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophys J 88 (1): 515-526.
130. Matsuoka T, Tomita S, Hamada H, Shiraki K. 2007. Amidated amino acids are prominent additives for preventing heat-induced aggregation of lysozyme. J Biosci Bioeng 103 (5): 440-443.
131. Holm NK, Jespersen SK, Thomassen LV, Wolff TY, Pankaj S, Thomsen LA, Christiansen G, Andersen CB, Knudsen AD, Otzen DE. 2007. Aggregation and fibrillation of bovine serum albumin. BBA-Proteins Proteom 1774 (9): 1128-1138.
132. Purohit VS, Middaugh CR, Balasubramanian SV. 2006. Influence of aggregation on immunogenicity of recombinant human factor VIII in hemophilia A mice. J Pharm Sci 95 (2): 358-371.
133. Andrews JM, Weiss WF, Roberts CJ. 2008. Nucleation, growth, and activation energies for seeded and unseeded aggregation of alpha-chymotrypsinogen A. Biochemistry (Mosc) 47 (8): 2397-2403.
134. Fedurkina NV, Belousova LV, Mitskevich LG, Zhou HM, Chang Z, Kurganov BI. 2006. Change in kinetic regime of protein aggregation with temperature increase. Thermal aggregation of rabbit muscle creatine kinase. Biochemistry (Mosc) 71 (3): 325-331.
135. Vermeer AW, Norde W. 2000. The thermal stability of immunoglobulin: Unfolding and aggregation of a multi-domain protein. Biophys J 78 (1): 394-404.
136. Eisenthal R, Peterson ME, Daniel RM, Danson MJ. 2006. The thermal behaviour of enzyme activity: Implications for biotechnology. Trends Biotechnol 24 (7): 289-292.
137. Fitzsimons SM, Mulvihill DM, Morris ER. 2007. Denaturation and aggregation processes in thermal gelation of whey proteins resolved by differential scanning calorimetry. Food Hydrocolloids 21 (4): 638-644.
138. Saluja A, Badkar AV, Zeng DL, Kalonia DS. 2007. Ultrasonic rheology of a monoclonal antibody (IgG2) solution: Implications for physical stability of proteins in high concentration formulations. J Pharm Sci 96 (12): 3181-3195.
139. Zhang J, Peng X, Jonas A, Jonas J. 1995. NMR study of the cold, heat, and pressure unfolding of ribonuclease A. Biochemistry 34 (27): 8631-8641.
140. Kosa T, Maruyama T, Otagiri M. 1998. Species differences of serum albumins: II. Chemical and thermal stability. Pharm Res 15 (3): 449-454.
141. Ferri C, Zignego AL, Pileri SA. 2002. Cryoglobulins. J Clin Pathol 55(1): 4-13.
142. Ramsland PA, Farrugia W. 2002. Crystal structures of human antibodies: A detailed and unfinished tapestry of immunoglobulin gene products. J Mol Recognit 15 (5): 248-259.
143. Sukumar M, Doyle BL, Combs JL, Pekar AH. 2004. Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association. Pharm Res 21 (7): 1087-1093.
144. Piedmonte DM, Summers C, McAuley A, Karamujic L, Ratnaswamy G. 2007. Sorbitol crystallization can lead to protein aggregation in frozen protein formulations. Pharm Res 24 (1): 136-146.
145. Heller MC, Carpenter JF, Randolph TW. 1997. Manipulation of lyophilization-induced phase separation: Implications for pharmaceutical proteins. Biotechnol Prog 13 (5): 590-596.
146. Heller MC, Carpenter JF, Randolph TW. 1999. Protein formulation and lyophilization cycle design: Prevention of damage due to freeze-concentration induced phase separation. Biotechnol Bioeng 63 (2): 166-174.
147. Schein CH. 1990. Solubility as a function of protein structure and solvent components. Biotechnology 8: 308-317.
148. Kohn WD, Kay CM, Hodges RS. 1997. Salt effects on protein stability: Two-stranded alpha-helical coiled-coils containing inter-or intrahelical ion pairs. J Mol Biol 267 (4): 1039-1052.
149. Vrkljan M, Foster TM, Powers ME, Henkin J, Porter WR, Staack H, Carpenter JF, Manning MC. 1994. Thermal stability of low molecular weight urokinase during heat treatment. II. Effect of polymeric additives. Pharm Res 11 (7): 1004-1008.
150. Fatouros A, Osterberg T, Mikaelsson M. 1997. Recombinant factor VIII SQ-Influence of oxygen, metal ions, pH and ionic strength on its stability in aqueous solution. Int J Pharm 155: 121-131.
151. Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. 2003. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (6950): 805-808.
152. DuBay KF, Pawar AP, Chiti F, Zurdo J, Dobson CM, Vendruscolo M. 2004. Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol 341 (5): 1317-1326.
153. Wang W, Antonsen K, Wang YJ, Wang DQ. 2008. pH dependent effect of glycosylation on protein stability. Eur J Pharm Sci 33 (2): 120-127.
154. Hartmann WK, Saptharishi N, Yang XY, Mitra G, Soman G. 2004. Characterization and analysis of thermal denaturation of antibodies by size exclusion high-performance liquid chromatography with quadruple detection. Anal Biochem 325 (2): 227-239.
155. Kerwin BA, Heller MC, Levin SH, Randolph TW. 1998. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at-20 degrees C of a recombinant hemoglobin. J Pharm Sci 87 (9): 1062-1068.
156. Advant SJ, Braswell EH, Kumar CV, Kalonia DS. 1995. The effect of pH and temperature on the self-association of recombinant human interleukin-2 as studied by equilibrium sedimentation. Pharm Res 12 (5): 637-641.
157. Tsai AM, van Zanten JH, Betenbaugh MJ. 1998. I. Study of protein aggregation due to heat denaturation: A structural approach using circular dichroism spectroscopy, nuclear magnetic resonance, and static light scattering. Biotechnol Bioeng 59 (3): 273-280.
158. Thirumangalathu R, Krishnan S, Brems DN, Randolph TW, Carpenter JF. 2006. Effects of pH, temperature, and sucrose on benzyl alcohol-induced aggregation of recombinant human granulocyte colony stimulating factor. J Pharm Sci 95 (7): 1480-1497.
159. Roy S, Henderson I, Nayar R, Randolph TW, Carpenter JF. 2008. Effect of pH on stability of recombinant botulinum serotype A vaccine in aqueous solution and during storage of freeze-dried formulations. J Pharm Sci. doi:10.1002/ jps.21409.
160. Shukla AA, Gupta P, Han X. 2007. Protein aggregation kinetics during protein A chromatography case study for an Fc fusion protein. J Chromatogr 1171 (1-2): 22-28.
161. Ejima D, Tsumoto K, Fukada H, Yumioka R, Nagase K, Arakawa T, Philo JS. 2007. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins 66 (4): 954-962.
162. Barteri M, Gaudiano MC, Rotella S, Benagiano G, Pala A. 2000. Effect of pH on the structure and aggregation of human glycodelin A. A comparison with beta-lactoglobulin A. BBA-Protein Struct M 1479 (12): 255-264.
163. Munishkina LA, Ahmad A, Fink AL, Uversky VN. 2008. Guiding protein aggregation with macromolecular crowding. Biochemistry 47 (34): 8993-9006.
164. Kurochkin IV, Procyk R, Bishop PD, Yee VC, Teller DC, Ingham KC, Medved LV. 1995. Domain structure, stability and domain-domain interactions in recombinant factor XIII. J Mol Biol 248 (2): 414-430.
165. Majhi PR, Ganta RR, Vanam RP, Seyrek E, Giger K, Dubin PL. 2006. Electrostatically driven protein aggregation: Beta-lactoglobulin at low ionic strength. Langmuir 22 (22): 9150-9159.
166. Chung K, Kim J, Cho BK, Ko BJ, Hwang BY, Kim BG. 2007. How does dextran sulfate prevent heat induced aggregation of protein? The mechanism and its limitation as aggregation inhibitor. Biochim Biophys Acta 1774 (2): 249-257.
167. Long X, Zhang C, Cheng J, Bi S. 2008. A novel method for study of the aggregation of protein induced by metal ion aluminum(III) using resonance Rayleigh scattering technique. Spectrochim Acta A Mol Biomol Spectrosc 69 (1): 71-77.
168. Rana A, Gupta TP, Bansal S, Kundu B. 2008. Formation of amyloid fibrils by bovine carbonic anhydrase. Biochim Biophys Acta 1784 (6): 930-935.
169. Kamat MS, Tolman GL, Brown JM. 1996. Formulation development of an antifibrin monoclonal antibody radiopharmaceutical. Pharm Biotechnol 9: 343-364.
170. Pikal MJ, Dellerman KM, Roy ML, Riggin RM. 1991. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharm Res 8 (4): 427-436.
171. Eberlein GA, Stratton PR, Wang YJ. 1994. Stability of rhbFGF as determined by UV spectroscopic measurements of turbidity. PDA J Pharm Sci Technol 48 (5): 224-230.
172. Paborji M, Pochopin NL, Coppola WP, Bogardus JB. 1994. Chemical and physical stability of chimeric L6, a mouse-human monoclonal antibody. Pharm Res 11 (May): 764-771.
173. Kita Y, Arakawa T. 2002. Salts and glycine increase reversibility and decrease aggregation during thermal unfolding of ribonuclease-A. Biosci Biotechnol Biochem 66 (4): 880-882.
174. Baussay K, Bon CL, Nicolai T, Durand D, Busnel JP. 2004. Influence of the ionic strength on the heat-induced aggregation of the globular protein beta-lactoglobulin at pH 7. Int J Biol Macromol 34 (1-2): 21-28.
175. Arnaudov LN, de Vries R. 2006. Strong impact of ionic strength on the kinetics of fibrilar aggregation of bovine beta-lactoglobulin. Biomacromolecules 7 (12): 3490-3498.
176. Kerstens S, Murray BS, Dickinson E. 2005. Confocal microscopy of heat-induced aggregation and gelation of beta-lactoglobulin in presence of non-ionic surfactant. Food Hydrocolloids 19 (3): 625-633.
177. Trevino SR, Scholtz JM, Pace CN. 2008. Measuring and increasing protein solubility. J Pharm Sci 97 (10): 4155-4166.
178. Bagger HL, Ogendal LH, Westh P. 2007. Solute effects on the irreversible aggregation of serum albumin. Biophys Chem 130 (1-2): 17-25.
179. Rezaei-Ghaleh N, Ebrahim-Habibi A, Moosavi-Movahedi AA, Nemat-Gorgani M. 2007. Role of electrostatic interactions in 2,2,2-trifluoroethanol-induced structural changes and aggregation of alpha-chymotrypsin. Arch Biochem Biophys 457 (2): 160-169.
180. Grudzielanek S, Smirnovas V, Winter R. 2007. The effects of various membrane physical-chemical properties on the aggregation kinetics of insulin. Chem Phys Lipids 149 (1-2): 28-39.
181. Xia Y, Park YD, Mu H, Zhou HM, Wang XY, Meng FG. 2007. The protective effects of osmolytes on arginine kinase unfolding and aggregation. Int J Biol Macromol 40 (5): 437-443.
182. Goyal K, Walton LJ, Tunnacliffe A. 2005. LEA proteins prevent protein aggregation due to water stress. Biochem J 388 (1): 151-157.
183. Beranger F, Crozet C, Goldsborough A, Lehmann S. 2008. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage. Biochem Biophys Res Commun 374 (1): 44-48.
184. Schule S, Schulz-Fademrecht T, Garidel P, Bechtold-Peters K, Friess W. 2008. Stabilization of IgG1 in spray-dried powders for inhalation. Eur J Pharm Biopharm 69 (3): 793-807.
185. Rondeau P, Armenta S, Caillens H, Chesne S, Bourdon E. 2007. Assessment of temperature effects on beta-aggregation of native and glycated albumin by FTIR spectroscopy and PAGE: Relations between structural changes and antioxidant properties. Arch Biochem Biophys 460 (1): 141-150.
186. Maclean DS, Qian Q, Middaugh CR. 2002. Stabilization of proteins by low molecular weight multi-ions. J Pharm Sci 91 (10): 2220-2229.
187. Unterhaslberger G, Schmitt C, Sanchez C, Appolonia NC, Raemy A. 2006. Heat denaturation and aggregation of beta-lactoglobulin enriched WPI in the presence of arginine HCl, NaCl and guanidinium HCl at pH 4.0 and 7.0. Food Hydrocolloids 20 (7): 1006-1019.
188. Ignatova Z, Gierasch LM. 2006. Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc Natl Acad Sci U S A 103 (36): 13357-13361.
189. Tsumoto K, Ejima D, Kita Y, Arakawa T. 2005. Review: Why is arginine effective in suppressing aggregation? Protein Pept Lett 12 (7): 613-619.
190. Hamada H, Takahashi R, Noguchi T, Shiraki K. 2008. Differences in the effects of solution additives on heat-and refolding-induced aggregation. Biotechnol Prog 24 (2): 436-443.
191. Lyutova EM, Kasakov AS, Gurvits BY. 2007. Effects of arginine on kinetics of protein aggregation studied by dynamic laser light scattering and tubidimetry techniques. Biotechnol Prog 23 (6): 1411-1416.
192. Das U, Hariprasad G, Ethayathulla AS, Manral P, Das TK, Pasha S, Mann A, Ganguli M, Verma AK, Bhat R, Chandrayan SK, Ahmed S, Sharma S, Kaur P, Singh TP, Srinivasan A. 2007. Inhibition of protein aggregation: Supramolecular assemblies of arginine hold the key. PLoS One 2 (11): e1176.
193. Ignatova Z, Gierasch LM. 2007. Effects of osmolytes on protein folding and aggregation in cells. Methods Enzymol 428: 355-372.
194. Kar K, Kishore N. 2007. Enhancement of thermal stability and inhibition of protein aggregation by osmolytic effect of hydroxyproline. Biopolymers 87 (5-6): 339-351.
195. Rezaei-Ghaleh N, Ebrahim HA, Moosavi MAA, Nemat GM. 2007. Effect of polyamines on the structure, thermal stability and 2,2,2-trifluoroethanol-induced aggregation of alpha-chymotrypsin. Int J Biol Macromol 41 (5): 597-604.
196. Schlieben NH, Niefind K, Schomburg D. 2004. Expression, purification, and aggregation studies of His-tagged thermoalkalophilic lipase from Bacillus thermocatenulatus. Protein Expr Purif 34 (1): 103-110.
197. Lam XM, Oeswein JQ, Ongpipattanakul B, Shahrokh Z, Wang SX, Weissburg RP, Wong RL. 2000. Stabilized antibody formulation. US6991790 B1.
198. Eronina TB, Chebotareva NA, Kurganov BI. 2005. Influence of osmolytes on inactivation and aggregation of muscle glycogen phosphorylase b by guanidine hydrochloride. Stimulation of protein aggregation under crowding conditions. Biochemistry (Mosc) 70 (9): 1020-1026.
199. Moussa CE, Mahmoodian F, Tomita Y, Sidhu A. 2008. Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: Insights into the protein chemistry of Parkinson's disease. Biochem Biophys Res Commun 365 (4): 833-839.
200. Joshi SB, Kamerzell TJ, McNown C, Middaugh CR. 2008. The interaction of heparin/polyanions with bovine, porcine, and human growth hormone. J Pharm Sci 97 (4): 1368-1385.
201. Arakawa T, Wen J, Philo JS. 1993. Densimetric determination of equilibrium binding of sucrose octasulfate with basic fibroblast growth factor. J Protein Chem 12 (6): 689-693.
202. Considine T, Patel HA, Singh H, Creamer LK. 2007. Influence of binding conjugated linoleic acid and myristic acid on the heat-and high-pressure-induced unfolding and aggregation of beta-lactoglobulin B. Food Chem 102 (4): 1270-1280.
203. Baynes BM, Trout BL 2004. Rational design of solution additives for the prevention of protein aggregation. Biophys J 87 (3): 1631-1639.
204. Zhang MZ, Wen J, Arakawa T, Prestrelski SJ. 1995. A new strategy for enhancing the stability of lyophilized protein: The effect of the reconstitution medium on keratinocyte growth factor. Pharm Res 12 (10): 1447-1452.
205. Vemuri S, Yu CT, Roosdorp N. 1993. Formulation and stability of recombinant alpha 1-antitrypsin. Pharm Biotechnol 5: 263-286.
206. Calamai M, Taddei N, Stefani M, Ramponi G, Chiti F. 2003. Relative influence of hydrophobicity and net charge in the aggregation of two homologous proteins. Biochemistry (Mosc) 42 (51): 15078-15083.
207. Arakawa T, Wen J, Philo JS. 1994. Stoichiometry of heparin binding to basic fibroblast growth factor. Arch Biochem Biophys 308 (1): 267-273.
208. Volkin DB, Tsai PK, Dabora JM, Gress JO, Burke CJ, Linhardt RJ, Middaugh CR. 1993. Physical stabilization of acidic fibroblast growth factor by polyanions. Arch Biochem Biophys 300 (1): 30-41.
209. Tsai AM, van Zanten JH, Betenbaugh MJ 1998. II. Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design. Biotechnol Bioeng 59 (3): 281-285.
210. Song C, Wang Q, Li CC. 2007. Characterization of the aggregation-prevention activity of p97/valosin-containing protein. Biochemistry 46 (51): 14889-14898.
211. Manning MC, Matsuura JE, Kendrick BS, Meyer JD, Dormish JJ, Vrkljian M, Ruth JR, Carpenter JF, Shefter E. 1995. Approaches for increasing the solution stability of proteins. Biotechnol Bioeng 48: 506-512.
212. Kehoe JJ, Morris ER, Brodkorb A. 2007. The influence of bovine serum albumin on beta-lactoglobulin denaturation, aggregation and gelation. Food Hydrocolloids 21 (56): 747-755.
213. Kubota S, Kubota H, Nagata K. 2006. Cytosolic chaperonin protects folding intermediates of G ss from aggregation by recognizing hydrophobic ss-strands. Proc Natl Acad Sci U S A 103 (22): 8360-8365.
214. Pivovarova AV, Chebotareva NA, Chernik IS, Gusev NB, Levitsky DI. 2007. Small heat shock protein Hsp27 prevents heat-induced aggregation of F-actin by forming soluble complexes with denatured actin. FEBS J 274 (22): 5937-5948.
215. Pivovarova AV, Mikhailova VV, Chernik IS, Chebotareva NA, Levitsky DI, Gusev NB. 2005. Effects of small heat shock proteins on the thermal denaturation and aggregation of F-actin. Biochem Biophys Res Commun 331 (4): 1548-1553.
216. Yamashita H, Kawamata J, Okawa K, Kanki R, Nakamizo T, Hatayama T, Yamanaka K, Takahashi R, Shimohama S. 2007. Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: Clues to a possible strategy for treating ALS. J Neurochem 102 (5): 1497-1505.
217. Lee S, Carson K, Rice FA, Good T. 2006. Small heat shock proteins differentially affect A beta aggregation and toxicity. Biochem Biophys Res Commun 347 (2): 527-533.
218. Linetsky M, Shipova E, Cheng R, Ortwerth BJ. 2008. Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins. Biochim Biophys Acta 1782 (1): 22-34.
219. Estrada LD, Soto C. 2006. Inhibition of protein misfolding and aggregation by small rationally-designed peptides. Curr Pharm Des 12 (20): 2557-2567.
220. Etienne MA, Aucoin JP, Fu Y, McCarley RL, Hammer RP. 2006. Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha, alpha-disubstituted amino acids. J Am Chem Soc 128 (11): 3522-3523.
221. Yazdanparast R, Esmaeili MA, Khodagholi F. 2007. Control of aggregation in protein refolding: Cooperative effects of artificial chaperone and cold temperature. Int J Biol Macromol 40 (2): 126-133.
222. Tokihiro K, Irie T, Uekama K. 1997. Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution. Chem Pharm Bull (Tokyo) 45 (3): 525-531.
223. Wang W, Wang YJ, Wang DQ. 2008. Dual effects of Tween 80 on protein stability. Int J Pharm 347 (1-2): 31-38.
224. Randolph TW, Jones LS. 2002. Surfactant-protein interactions. Pharm Biotechnol 13: 159-175.
225. Bam NB, Randolph TW, Cleland JL. 1995. Stability of protein formulations: Investigation of surfactant effects by a novel EPR spectroscopic technique. Pharm Res 12 (1): 2-11.
226. Chou DK, Krishnamurthy R, Randolph TW, Carpenter JF, Manning MC. 2005. Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. J Pharm Sci 94 (6): 1368-1381.
227. Kerwin BA. 2008. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways. J Pharm Sci 97 (8): 2924-2935.
228. Bam NB, Cleland JL, Yang J, Manning MC, Carpenter JF, Kelley RF, Randolph TW. 1998. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci 87 (12): 1554-1559.
229. Arakawa T, Kita Y. 2000. Protection of bovine serum albumin from aggregation by Tween 80. J Pharm Sci 89 (5): 646-651.
230. Katakam M, Banga AK. 1997. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm Dev Technol 2 (2): 143-149.
231. Rozema D, Gellman SH. 1996. Artificial chaperone-assisted refolding of carbonic anhydrase B. J Biol Chem 271 (7): 3478-3487.
232. Treuheit MJ, Kosky AA, Brems DN. 2002. Inverse relationship of protein concentration and aggregation. Pharm Res 19 (4): 511-516.
233. Panyukov YV, Nemykh MA, Dobrov EN, Drachev VA. 2008. Surfactant-induced amorphous aggregation of tobacco mosaic virus coat protein: A physical methods approach. Macromol Biosci 8 (2): 199-209.
234. Panyukov YV, Nemykh MA, Rafikova ER, Kurganov BI, Yaguzhinsky LS, Arutyunyan AM, Drachev VA, Dobrov EN. 2006. Low cetyltrimethylammonium bromide concentrations induce reversible amorphous aggregation of tobacco EXTERNAL FACTORS AFFECTING PROTEIN AGGREGATION 193 mosaic virus and its coat protein at room temperature. Int J Biochem Cell Biol 38 (4): 533-543.
235. Collins T, D'Amico S, Georlette D, Marx JC, Huston AL, Feller G. 2006. A nondetergent sulfobetaine prevents protein aggregation in microcalorimetric studies. Anal Biochem 352 (2): 299-301.
236. Zhang Y, Roy S, Jones LS, Krishnan S, Kerwin BA, Chang BS, Manning MC, Randolph TW, Carpenter JF. 2004. Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution. J Pharm Sci 93 (12): 3076-3089.
237. Roy S, Jung R, Kerwin BA, Randolph TW, Carpenter JF. 2005. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. J Pharm Sci 94 (2): 382-396.
238. Harn N, Allan C, Oliver C, Middaugh CR. 2007. Highly concentrated monoclonal antibody solutions: Direct analysis of physical structure and thermal stability. J Pharm Sci 96 (3): 532-546.
239. Ellis RJ, Minton AP. 2006. Protein aggregation in crowded environments. Biol Chem 387 (5): 485-497.
240. Minton AP. 2006. Macromolecular crowding. Curr Biol 16(8): R269-R271.
241. Guo J, Harn N, Robbins A, Dougherty R, Middaugh CR. 2006. Stability of helix-rich proteins at high concentrations. Biochemistry 45 (28): 8686-8696.
242. Jimenez M, Rivas G, Minton AP. 2007. Quantitative characterization of weak self-association in concentrated solutions of immunoglobulin G via the measurement of sedimentation equilibrium and osmotic pressure. Biochemistry (Mosc) 46 (28): 8373-8378.
243. Elshereef R, Budman H, Moresoli C, Legge RL. 2008. Fluorescence-based soft-sensor for monitoring beta-lactoglobulin and alpha-lactalbumin solubility during thermal aggregation. Biotechnol Bioeng 99 (3): 567-577.
244. Sukumar M, Doyle BL, Combs JL, Pekar AH. 2004. Opalescent appearance of an IgG1 antibody at high concentrations and its relationship to noncovalent association. Pharm Res 21 (7): 1087-1093.
245. Pease LF III, Elliott JT, Tsai DH, Zachariah MR, Tarlov MJ. 2008. Determination of protein aggregation with differential mobility analysis: application to IgG antibody. Biotechnol Bioeng 101 (6): 1214-1222.
246. Ramani K, Purohit V, Middaugh CR, Balasubramanian SV. 2005. Aggregation kinetics of recombinant human FVIII (rFVIII). J Pharm Sci 94 (9): 2023-2029.
247. Roefs SP, De Kruif KG. 1994. A model for the denaturation and aggregation of beta-lactoglobulin. Eur J Biochem 226 (3): 883-889.
248. Alexandrescu AT, Rathgeb-Szabo K. 1999. An NMR investigation of solution aggregation reactions preceding the misassembly of acid-denatured cold shock protein A into fibrils. J Mol Biol 291 (5): 1191-1206.
249. Golub N, Meremyanin A, Markossian K, Eronina T, Chebotareva N, Asryants R, Muronets V, Kurganov B. 2007. Evidence for the formation of start aggregates as an initial stage of protein aggregation. FEBS Lett 581 (22): 4223-4227.
250. Mounsey JS, O'Kennedy BT. 2007. Conditions limiting the influence of thiol-disulphide interchange reactions on the heat-induced aggregation kinetics of beta-lactoglobulin. Int Dairy J 17 (9): 1034-1042.
251. Powers ET, Powers DL. 2008. Mechanisms of protein fibril formation: Nucleated polymerization with competing off-pathway aggregation. Biophys J 94(2): 379-391.
252. Huus K, Havelund S, Olsen HB, van de Weert M, Frokjaer S. 2005. Thermal dissociation and unfolding of insulin. Biochemistry (Mosc) 44 (33): 11171-11177.
253. Wang W, Wang YJ, Kelner DN. 2003. Coagulation factor VIII: Structure and stability. Int J Pharm 259 (1-2): 1-15.
254. Alcaraz LA, Donaire A. 2004. Unfolding process of rusticyanin-Evidence of protein aggregation. Eur J Biochem 271 (21): 4284-4292.
255. Giese A, Levin J, Bertsch U, Kretzschmar H. 2004. Effect of metal ions on de novo aggregation of full-length prion protein. Biochem Biophys Res Commun 320 (4): 1240-1246.
256. Derrick TS, Kashi RS, Durrani M, Jhingan A, Middaugh CR. 2004. Effect of metal cations on the conformation and inactivation of recombinant human factor VIII. J Pharm Sci 93 (10): 2549-2557.
257. Vessely CR, Carpenter JF, Schwartz DK. 2005. Calcium-induced changes to the molecular conformation and aggregate structure of beta-casein at the air-water interface. Biomacromolecules 6 (6): 3334-3344.
258. Capanni C, Taddei N, Gabrielli S, Messori L, Orioli P, Chiti F, Stefania M, Ramponia G. 2004. Investigation of the effects of copper ions on protein aggregation using a model system. Cell Mol Life Sci 61 (7-8): 982-991.
259. Simmons MJH, Jayaraman P, Fryer PJ. 2007. The effect of temperature and shear rate upon the aggregation of whey protein and its implications for milk fouling. J Food Eng 79 (2): 517-528.
260. Bermudez O, Forciniti D. 2004. Aggregation and denaturation of antibodies: A capillary electrophoresis, dynamic light scattering, and aqueous two-phase partitioning study. J Chromatogr B 807 (1): 17-24.
261. Katakam M, Bell LN, Banga AK. 1995. Effect of surfactants on the physical stability of recombinant human growth hormone. J Pharm Sci 84 (6): 713-716.
262. Zhou P, Liu X, Labuza TP. 2008. Moisture-induced aggregation of whey proteins in a protein/buffer model system. J Agric Food Chem 56 (6): 2048-2054.
263. Lee YN, Chen LK, Ma HC, Yang HH, Li HP, Lo SY. 2005. Thermal aggregation of SARS-CoV membrane protein. J Virol Methods 129 (2): 152-161.
264. Patro SY, Przybycien TM. 1994. Simulations of kinetically irreversible protein aggregate structure. Biophys J 66: 1274-1289.
265. Gotte G, Libonati M. 2008. Oligomerization of ribonuclease A under reducing conditions. Biochim Biophys Acta 1784 (4): 638-650.
266. Maeda R, Ado K, Takeda N, Taniguchi Y. 2007. Promotion of insulin aggregation by protein disulfide isomerase. Biochim Biophys Acta 1774 (12): 1619-1627.
267. Schokker EP, Singh H, Creamer LK. 2000. Heat-induced aggregation of beta-lactoglobulin A and B with alpha-lactalbumin. Int Dairy J 10 (12): 843-853.
268. Gorbenko GP, Ioffe VM, Kinnunen PK. 2007. Binding of lysozyme to phospholipid bilayers: Evidence for protein aggregation upon membrane association. Biophys J 93 (1): 140-153.
269. Creusot N, Gruppen H. 2007. Enzyme-induced aggregation and gelation of proteins. Biotechnol Adv 25 (6): 597-601.
270. Pace CN, Trevino S, Prabhakaran E, Scholtz JM. 2004. Protein structure, stability and solubility in water and other solvents. Philos Trans R Soc Lond B Biol Sci 359 (1448): 1225-1234; discussion 1234-1235.
271. Feng S, Yan YB. 2008. Effects of glycerol on the compaction and stability of the wild type and mutated rabbit muscle creatine kinase. Proteins 71 (2): 844-854.
272. Amani M, Yousefi R, Moosavi-Movahedi AA, Pintus F, Mura A, Floris G, Kurganov BI, Saboury AA. 2008. Structural changes and aggregation process of Cu/containing amine oxidase in the presence of 2,2,2 '-trifluoroethanol. Protein Pept Lett 15 (5): 521-527.
273. Sukumar M, Storms SM, De Felippis MR. 2005. Non-native intermediate conformational states of human growth hormone in the presence of organic solvents. Pharm Res 22 (5): 789-796.
274. Cholewinski M, Luckel B, Horn H. 1996. Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison. Pharm Acta Helv 71 (6): 405-419.
275. Joshi O, McGuire J, Wang DQ. 2008. Adsorption and function of recombinant factor VIII at solid-water interfaces in the presence of Tween-80. J Pharm Sci. doi:10.1002/jps.21333.
276. Holmberg M, Stibius KB, Ndoni S, Larsen NB, Kingshott P, Hou XL. 2007. Protein aggregation and degradation during iodine labelling and its consequences for protein adsorption to biomaterials. Anal Biochem 361 (1): 120-125.
277. Santos O, Nylander T, Paulsson M, Trägårdh C. 2006. Whey protein adsorption onto steel surfaces-Effect of temperature, flow rate, residence time and aggregation. J Food Eng 74 (4): 468-483.
278. Joshi O, McGuire J. 2008. Adsorption behavior of lysozyme and Tween 80 at hydrophilic and hydrophobic silica-water interfaces. Appl Biochem Biotechnol. doi:10.1007/s12010-008-8246-8.
279. Kueltzo LA, Wang W, Randolph TW, Carpenter JF. 2008. Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. J Pharm Sci 97 (5): 1801-1812.
280. Gryniewicz CM, Kauffman JF. 2008. Multivariate calibration of covalent aggregate fraction to the Raman spectrum of regular human insulin. J Pharm Sci 97 (9): 3727-3734.
281. Jones LS, Kaufmann A, Middaugh CR. 2005. Silicone oil induced aggregation of proteins. J Pharm Sci 94 (4): 918-927.
282. McGuffey MK, Otter DE, Zanten JHv, Foegeding EA. 2007. Solubility and aggregation of commercial alpha-lactalbumin at neutral pH. Int Dairy J 17 (10): 1168-1178.
283. Kerwin BA, Remmele RL Jr. 2007. Protect from light: Photodegradation and protein biologics. J Pharm Sci 96 (6): 1468-1479.
284. Li DY, Borkman RF, Wang RH, Dillon J. 1990. Mechanisms of photochemically produced turbidity in lens protein solutions. Exp Eye Res 51 (6): 663-669.
285. Vanhooren A, Devreese B, Vanhee K, Van Beeumen J, Hanssens I. 2002. Photoexcitation of tryptophan groups induces reduction of two disulfide bonds in goat alpha-lactalbumin. Biochemistry (Mosc) 41 (36): 11035-11043.
286. Davies MJ. 2003. Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 305 (3): 761-770.
287. Georgiou G, Valax P. 1999. Isolating inclusion bodies from bacteria. Methods Enzymol 309: 48-58.
288. de Groot NS, Ventura S. 2006. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J Biotechnol 125 (1): 110-113.
289. Hao Y, Chu J, Wang Y, Zhuang Y, Zhang S. 2007. The inhibition of aggregation of recombinant human consensus interferon-alpha mutant during Pichia pastoris fermentation. Appl Microbiol Biotechnol 74 (3): 578-584.
290. Wu D, Hao YY, Chu J, Zhuang YP, Zhang SL. 2008. Inhibition of degradation and aggregation of recombinant human consensus interferon-alpha mutant expressed in Pichia pastoris with complex medium in bioreactor. Appl Microbiol Biotechnol. doi:10.1007/s00253-008-1629-5.
291. Bahrami A, Shojaosadati SA, Khalilzadeh R, Mohammadian J, Vashghani Farahani E, Masoumian MR. 2008. Prevention of human G-CSF protein aggregation in recombinant Pichia pastoris fed-batch fermentation using additives. Biotechnol Appl Biochem. doi:10.1042/BA20070267.
292. Chaderjian WB, Chin ET, Harris RJ, Etcheverry TM. 2005. Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed. Biotechnol Prog 21 (2): 550-553.
293. Sola RJ, Griebenow K. 2008. Effects of glycosylation on the stability of protein pharmaceuticals. J Pharm Sci. doi:10.1002/jps.21504.
294. Lim KH, Chang HI. 2006. O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1. FEBS Lett 580 (19): 4645-4652.
295. Srour MA, Grupp J, Aburubaiha Z, Albert T, Brondke H, Oldenburg J, Schwaab R. 2008. Modified expression of coagulation factor VIII by addition of a glycosylation site at the N terminus of the protein. Ann Hematol 87 (2): 107-112.
296. Singleton KD, Wischmeyer PE. 2008. Glutamine induces heat shock protein expression via O-glycosylation and phosphorylation of HSF-1 and Sp1. JPEN J Parenter Enteral Nutr 32 (4): 371-376.
297. Castle AM, Castle JD. 1998. Enhanced glycosylation and sulfation of secretory proteoglycans is coupled to the expression of a basic secretory protein. Mol Biol Cell 9 (3): 575-583.
298. Weintraub BD, Stannard BS, Meyers L. 1983. Glycosylation of thyroid-stimulating hormone in pituitary tumor cells: Influence of high mannose oligosaccharide units on subunit aggregation, combination, and intracellular degradation. Endocrinology 112 (4): 1331-1345.
299. Mishra R, Seckler R, Bhat R. 2005. Efficient refolding of aggregation-prone citrate synthase by polyol osmolytes: How well are protein folding and stability aspects coupled? J Biol Chem 280 (16): 15553-15560.
300. De Bernardez Clark E, Schwarz E, Rudolph R. 1999. Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol 309: 217-236.
301. Clark EDB. 1998. Refolding of recombinant proteins. Curr Opin Biotechnol 9 (2): 157-163.
302. Klein J, Dhurjati P. 1995. Protein aggregation kinetics in an Escherichia coli strain overexpressing a Salmonella typhimurium CheY mutant gene. Appl Environ Microbiol 61 (4): 1220-1225.
303. Georgiou G, Valax P, Ostermeier M, Horowitz PM. 1994. Folding and aggregation of TEM beta-lactamase: Analogies with the formation of inclusion bodies in Escherichia coli. Protein Sci 3 (11): 1953-1960.
304. Karuppiah N, Sharma A. 1995. Cyclodextrins as protein folding aids. Biochem Biophys Res Commun 211 (1): 60-66.
305. Xie Y, Wetlaufer DB. 1996. Control of aggregation in protein refolding: The temperature-leap tactic. Protein Sci 5 (3): 517-523.
306. Stempfer G, Holl-Neugebauer B, Rudolph R. 1996. Improved refolding of an immobilized fusion protein. Nat Biotechnol 14 (3): 329-334.
307. Gupta P, Hall CK, Voegler AC. 1998. Effect of denaturant and protein concentrations upon protein refolding and aggregation: A simple lattice model. Protein Sci 7 (12): 2642-2652.
308. Cardamone M, Puri NK, Brandon MR. 1995. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies. Biochemistry 34 (17): 5773-5794.
309. Kim D, Yu MH. 1996. Folding pathway of human alpha 1-antitrypsin: Characterization of an intermediate that is active but prone to aggregation. Biochem Biophys Res Commun 226 (2): 378-384.
310. Rariy RV, Klibanov AM. 1997. Correct protein folding in glycerol. Proc Natl Acad Sci U S A 94: 13520-13523.
311. Yasuda M, Murakami Y, Sowa A, Ogino H, Ishikawa H. 1998. Effect of additives on refolding of a denatured protein. Biotechnol Prog 14 (4): 601-606.
312. Maeda Y, Ueda T, Imoto T. 1996. Effective renaturation of denatured and reduced immunoglobulin G in vitro without assistance of chaperone. Protein Eng 9: 95-100.
313. Cleland JL, Builder SE, Swartz JR, Winkler M, Chang JY, Wang DI. 1992. Polyethylene glycol enhanced protein refolding. Biotechnology (N Y) 10 (9): 1013-1019.
314. Wetlaufer DB, Xie Y. 1995. Control of aggregation in protein refolding: A variety of surfactants promote renaturation of carbonic anhydrase II. Protein Sci 4 (8): 1535-1543.
315. Monterroso B, Minton AP. 2007. Effect of high concentration of inert cosolutes on the refolding of an enzyme: Carbonic anhydrase B in sucrose and Ficoll 70. J Biol Chem 282 (46): 33452-33458.
316. van den Berg B, Ellis RJ, Dobson CM. 1999. Effects of macromolecular crowding on protein folding and aggregation. EMBO J 18 (24): 6927-6933.
317. Hevehan D, De Bernardez-Clark E. 1997. Oxidative renaturation of lysozyme at high concentrations. Biotechnol Bioeng 54: 221-230.
318. Stigter D, Dill KD. 1993. Theory for protein solubilities. Fluid Phase Equilib 82: 237-249.
319. Hamada H, Shiraki K. 2007. L-argininamide improves the refolding more effectively than L-arginine. J Biotechnol 130 (2): 153-160.
320. Kuhlman B, Luisi DL, Evans PA, Raleigh DP. 1998. Global analysis of the effects of temperature and denaturant on the folding and unfolding kinetics of the N-terminal domain of the protein L9. J Mol Biol 284 (5): 1661-1670.
321. Scalley ML, Baker D. 1997. Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability. Proc Natl Acad Sci U S A 94 (20): 10636-10640.
322. Clarke AR, Waltho JP. 1997. Protein folding and intermediates. Curr Opin Biotechnol 8 (4): 400-410.
323. King J. 1997. Refolding with a piece of the ring. Nat Biotechnol 15 (6): 514-515.
324. Golbik R, Zahn R, Harding SE, Fersht AR. 1998. Thermodynamic stability and folding of GroEL minichaperones. J Mol Biol 276 (2): 505-515.
325. Thomas JG, Ayling A, Baneyx F. 1997. Molecular chaperones, folding catalysts, and the recovery of active recombinant proteins from E. coli. To fold or to refold. Appl Biochem Biotechnol 66 (3): 197-238.
326. Rozema D, Gellman SH. 1996. Artificial chaperone-assisted refolding of denatured-reduced lysozyme: Modulation of the competition between renaturation and aggregation. Biochemistry 35 (49): 15760-15771.
327. Stockel J, Doring K, Malotka J, Jahnig F, Dornmair K. 1997. Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. Eur J Biochem 248 (3): 684-691.
328. Yamaguchi S, Yamamoto E, Tsukiji S, Nagamune T. 2008. Successful control of aggregation and folding rates during refolding of denatured lysozyme by adding N-methylimidazolium cations with various N '-substituents. Biotechnol Prog 24 (2): 402-408.
329. Maeda Y, Yamada H, Ueda T, Imoto T. 1996. Effect of additives on the renaturation of reduced lysozyme in the presence of 4 m urea. Protein Eng 9: 461-465.
330. Arakawa T, Tsumoto K. 2003. The effects of arginine on refolding of aggregated proteins: Not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 304 (1): 148-152.
331. Tsumoto K, Umetsu M, Kumagai I, Ejima D, Arakawa T. 2003. Solubilization of active green fluorescent protein from insoluble particles by guanidine and arginine. Biochem Biophys Res Commun 312 (4): 1383-1386.
332. Phillips J, Drumm A, Harrison P, Bird P, Bhamra K, Berrie E, Hale G. 2001. Manufacture and quality control of CAMPATH-1 antibodies for clinical trials. Cytotherapy 3 (3): 233-242.
333. Heavner GA, Arakawa T, Philo JS, Calmann MA, Labrenz S. 2007. Protein isolated from biopharmaceutical formulations cannot be used for comparative studies: Follow-up to "a case study using Epoetin Alfa from Epogen and EPREX." J Pharm Sci 96 (12): 3214-3225.
334. Cromwell ME, Hilario E, Jacobson F. 2006. Protein aggregation and bioprocessing. AAPS J 8 (3): E572-E579.
335. Chang BS, Kendrick BS, Carpenter JF. 1996. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J Pharm Sci 85 (12): 1325-1330.
336. Lee LS. 1997. Stabilized monomeric protein compositions. US5656730, Enzon, Inc.
337. Wang W. 2000. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203 (1-2): 1-60.
338. Nakagawa K, Hottot A, Vessot S, Andrieu J. 2006. Influence of controoled nucleation by ultrasounds on ice morphology of froaen formulations for pharmaceutical proteins freeze-drying. Chem Eng Proc 45: 783-791.
339. Eckhardt BM, Oeswein JQ, Bewley TA. 1991. Effect of freezing on aggregation of human growth hormone. Pharm Res 8 (11): 1360-1364.
340. Anchordoquy TJ, Carpenter JF. 1996. Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch Biochem Biophys 332 (2): 231-238.
341. Nema S, Avis KE. 1992. Freeze-thaw studies of a model protein, lactate dehydrogenase, in the presence of cryoprotectants. J Parenter Sci Technol 47: 76-83.
342. Lashmar UT, Vanderburgh M, Little SJ. 2007. Bulk freeze-thawing of macromolecules. Bioprocess Int 5: 44-54.
343. Farruggia B, Garcia G, D'Angelo C, Pico G. 1997. Destabilization of human serum albumin by polyethylene glycols studied by thermodynamical equilibrium and kinetic approaches. Int J Biol Macromol 20 (1): 43-51.
344. Lee LS. 1997. Stabilized monomeric protein compositions. US 5656730.
345. Bush L, Webb C, Bartlett L, Burnett B. 1998. The formulation of recombinant factor IX: Stability, robustness, and convenience. Semin Hematol 35 (2 Suppl. 2): 18-21.
346. Kreilgaard L, Jones LS, Randolph TW, Frokjaer S, Flink JM, Manning MC, Carpenter JF. 1998. Effect of Tween 20 on freeze-thawing-and agitation-induced aggregation of recombinant human factor XIII. J Pharm Sci 87 (12): 1597-1603.
347. Volkin DB, Klibanov AM. 1989. Minimizing protein inactivation. In Creighton TE, ed., Protein Function a Practical Approach. Oxford, England: Information Press, pp. 1-24.
348. Kiese S, Papppenberger A, Friess W, Mahler HC. 2008. Shaken, not stirred: Mechanical stress testing of an IgG1 antibody. J Pharm Sci. doi:10.1002/jps.21328.
349. Levine HL, Ransohoff TC, Kawahata RT, McGregor WC. 1991. The use of surface tension measurements in the design of antibody-based product formulations. J Parenter Sci Technol 45 (3): 160-165.
350. Kueltzo LA. 2004. Formulation Strategies for Protein Therapeutics. Boston: IBC Life Sciences.
351. Biddlecombe JG, Craig AV, Zhang H, Uddin S, Mulot S, Fish BC, Bracewell DG. 2007. Determining antibody stability: Creation of solid-liquid interfacial effects within a high shear environment. Biotechnol Prog 23 (5): 1218-1222.
352. Kwon YM, Baudys M, Knutson K, Kim SW. 2001. In situ study of insulin aggregation induced by water-organic solvent interface. Pharm Res 18 (12): 1754-1759.
353. Kerwin BA, Akers MJ, Apostol I, Moore-Einsel C, Etter JE, Hess E, Lippincott J, Levine J, Mathews AJ, Revilla-Sharp P, Schubert R, Looker DL. 1999. Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications. J Pharm Sci 88 (1): 79-88.
354. Grácia-JuliáA, RenéM, Cortés MM, Picart L, López PT, Chevalier D, Dumay E. 2008. Effect of dynamic high pressure on whey protein aggregation: a 200 AGGREGATION OF THERAPEUTIC PROTEINS comparison with the effect of continuous short-time thermal treatments. Food Hydrocolloids 22 (6): 1014-1032.
355. Patel HA, Singh H, Havea P, Considine T, Creamer LK. 2005. Pressure-induced unfolding and aggregation of the proteins in whey protein concentrate solutions. J Agric Food Chem 53 (24): 9590-9601.
356. Seefeldt MB, Kim YS, Tolley KP, Seely J, Carpenter JF, Randolph TW. 2005. High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: Thermodynamics, kinetics, and application to accelerated formulation studies. Protein Sci 14 (9): 2258-2266.
357. Huppertz T, Fox PF, de Kruif KG, Kelly AL. 2006. High pressure-induced changes in bovine milk proteins: a review. Biochim Biophys Acta 1764 (3): 593-598.
358. Kolakowski P, Dumay E, Cheftel JC. 2001. Effects of high pressure and low temperature on beta-lactoglobulin unfolding and aggregation. Food Hydrocolloids 15 (3): 215-232.
359. St John RJ, Carpenter JF, Balny C, Randolph TW. 2001. High pressure refolding of recombinant human growth hormone from insoluble aggregates. Structural transformations, kinetic barriers, and energetics. J Biol Chem 276 (50): 46856-46863.
360. St John RJ, Carpenter JF, Randolph TW. 1999. High pressure fosters protein refolding from aggregates at high concentrations. Proc Natl Acad Sci U S A 96 (23): 13029-13033.
361. St John RJ, Carpenter JF, Randolph TW. 2002. High-pressure refolding of disulfide-cross-linked lysozyme aggregates: Thermodynamics and optimization. Biotechnol Prog 18 (3): 565-571.
362. Kuhlman B, Yang HY, Boice JA, Fairman R, Raleigh DP. 1997. An exceptionally stable helix from the ribosomal protein L9: Implications for protein folding and stability. J Mol Biol 270 (5): 640-647.
363. Rupley JA, Careri G. 1991. Protein hydration and function. Adv Protein Chem 41: 37-172.
364. Abdul-Fattah AM, Lechuga-Ballesteros D, Kalonia DS, Pikal MJ. 2008. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state. J Pharm Sci 97 (1): 163-184.
365. Salnikova MS, Middaugh CR, Rytting JH. 2008. Stability of lyophilized human growth hormone. Int J Pharm 358 (1-2): 108-113.
366. Yoshioka S, Miyazaki T, Aso Y, Kawanishi T. 2007. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose. Pharm Res 24 (9): 1660-1667.
367. Yu Z, Johnston KP, Williams RO III. 2006. Spray freezing into liquid versus spray-freeze drying: Influence of atomization on protein aggregation and biological activity. Eur J Pharm Sci 27 (1): 9-18.
368. Sarciaux JM, Mansour S, Hageman MJ, Nail SL. 1999. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. J Pharm Sci 88 (12): 1354-1361.
369. Cleland JL, Lam X, Kendrick B, Yang J, Yang TH, Overcashier D, Brooks D, Hsu C, Carpenter JF. 2001. A specific molar ratio of stabilizer to protein is EXTERNAL FACTORS AFFECTING PROTEIN AGGREGATION 201 required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci 90 (3): 310-321.
370. Hagiwara H, Yuasa H, Yamamoto Y. 2000. Stabilized human monoclonal antibody preparation. US6165467.
371. Ressing ME, Jiskoot W, Talsma H, Van Ingen CW, Crommelin DJ. 1992. Influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharm Res 9 (Feb): 266-270.
372. Andya JD, Hsu CC, Shire SJ. 2003. Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations. AAPS PharmSci 5 (2): E10.
373. Morales AA, Nunez-Gandolff G, Perez NP, Veliz BC, Caballero-Torres I, Duconge J, Fernandez E, Crespo FZ, Veloso A, Iznaga-Escobar N. 1999. Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: Additives, biodistribution, and stability. Nucl Med Biol 26 (6): 717-723.
374. Lueckel B, Helk B, Bodmer D, Leuenberger H. 1998. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage. Pharm Dev Technol 3 (3): 337-346.
375. Kreilgaard L, Frokjaer S, Flink JM, Randolph TW, Carpenter JF. 1998. Effects of additives on the stability of recombinant human factor XIII during freeze-drying and storage in the dried solid. Arch Biochem Biophys 360 (1): 121-134.
376. Volkin DB, Middaugh CR. 1996. The characterization, stabilization, and formulation of acidic fibroblast growth factor. Pharm Biotechnol 9: 181-217.
377. Webb SD, Cleland JL, Carpenter JF, Randolph TW. 2003. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma. J Pharm Sci 92 (4): 715-729.
378. Maury M, Murphy K, Kumar S, Mauerer A, Lee G. 2005. Spray-drying of proteins: Effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G. Eur J Pharm Biopharm 59 (2): 251-261.
379. Andya JD, Maa YF, Costantino HR, Nguyen PA, Dasovich N, Sweeney TD, Hsu CC, Shire SJ. 1999. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm Res 16 (3): 350-358.
380. Maa YF, Nguyen PA, Hsu SW. 1998. Spray-drying of air-liquid interface sensitive recombinant human growth hormone. J Pharm Sci 87 (2): 152-159.
381. Webb SD, Golledge SL, Cleland JL, Carpenter JF, Randolph TW. 2002. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. J Pharm Sci 91 (6): 1474-1487.
382. Burke PA, Klumb LA, Herberger JD, Nguyen XC, Harrell RA, Zordich M. 2004. Poly(lactide-co-glycolide) microsphere formulations of darbepoetin alfa: Spray drying is an alternative to encapsulation by spray-freeze drying. Pharm Res 21 (3): 500-506.
383. Nguyen XC, Herberger JD, Burke PA. 2004. Protein powders for encapsulation: A comparison of spray-freeze drying and spray drying of darbepoetin alfa. Pharm Res 21 (3): 507-514.
384. Costantino HR, Firouzabadian L, Hogeland K, Wu C, Beganski C, Carrasquillo KG, Cordova M, Griebenow K, Zale SE, Tracy MA. 2000. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm Res 17 (11): 1374-1383.
385. Jovanovic N, Bouchard A, Sutter M, Van Speybroeck M, Hofland GW, Witkamp GJ, Crommelin DJ, Jiskoot W. 2008. Stable sugar-based protein formulations by supercritical fluid drying. Int J Pharm 346 (1-2): 102-108.
386. Castellanos IJ, Crespo R, Griebenow K. 2003. Poly(ethylene glycol) as stabilizer and emulsifying agent: A novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J Control Release 88 (1): 135-145.
387. Wei G, Lu LF, Lu WY. 2007. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by pluronic surfactants during microencapsulation. Int J Pharm 338 (1-2): 125-132.
388. Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. 2008. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release 130 (3): 259-265.
389. Sah H. 1999. Stabilization of proteins against methylene chloride/water interface-induced denaturation and aggregation. J Control Release 58 (2): 143-151.
390. Kanaoka E, Nagata S, Hirano K. 1999. Stabilization of aerosolized IFN-gamma by liposomes. Int J Pharm 188 (2): 165-172.
391. Ip AY, Arakawa T, Silvers H, Ransone CM, Niven RW. 1995. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization. J Pharm Sci 84 (10): 1210-1214.
392. Assemand E, Lacroix M, Mateescu MA. 2003. L-tyrosine prevents aggregation of therapeutic proteins by gamma-irradiation. Biotechnol Appl Biochem 38 (Pt 2): 151-156.
393. Kang J, Lambert O, Ausborn M, Schwendeman SP. 2008. Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders. Int J Pharm 357 (1-2): 235-243.
394. Costantino HR, Griebenow K, Mishra P, Langer R, Klibanov AM. 1995. Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form. Biochim Biophys Acta 1253 (1): 69-74.
395. Chang LL, Shepherd D, Sun J, Ouellette D, Grant KL, Tang XC, Pikal MJ. 2005. Mechanism of protein stabilization by sugars during freeze-drying and storage: Native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci 94 (7): 1427-1444.
396. Roy ML, Pikal MJ, Rickard EC, Maloney AM. 1992. The effects of formulation and moisture on the stability of a freeze-dried monoclonal antibody-vinca conjugate: A test of the WLF glass transition theory. Dev Biol Stand 74: 323-339; discussion 340.
397. Pikal MJ, Rigsbee D, Roy ML, Galreath D, Kovach KJ, Wang BS, Carpenter JF, Cicerone MT. 2008. Solid state chemistry of proteins: II. The correlation of storage stability of freeze-dried human growth hormone (hGH) with structure and dynamics in the glassy solid. J Pharm Sci 97 (12): 5106-5121.
398. Jain NK, Roy I. 2008. Role of trehalose in moisture-induced aggregation of bovine serum albumin. Eur J Pharm Biopharm 69 (3): 824-834.
399. Chang BS, Reeder G, Carpenter JF. 1996. Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist. Pharm Res 13 (2): 243-249.
400. Hora MS, Rana RK, Smith FW. 1992. Lyophilized formulations of recombinant tumor necrosis factor. Pharm Res 9 (1): 33-36.
401. Garzon-Rodriguez W, Koval RL, Chongprasert S, Krishnan S, Randolph TW, Warne NW, Carpenter JF. 2004. Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures. J Pharm Sci 93 (3): 684-696.
402. Strickley RG, Anderson BD. 1997. Solid-state stability of human insulin. II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2-5 solutions: Stabilization against covalent dimer formation. J Pharm Sci 86 (6): 645-653.
403. Kreilgaard L, Frokjaer S, Flink JM, Randolph TW, Carpenter JF. 1999. Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid. J Pharm Sci 88 (3): 281-290.
404. Costantino HR, Schwendeman SP, Griebenow K, Klibanov AM, Langer R. 1996. The secondary structure and aggregation of lyophilized tetanus toxoid. J Pharm Sci 85 (12): 1290-1293.
405. Sane SU, Wong R, Hsu CC. 2004. Raman spectroscopic characterization of drying-induced structural changes in a therapeutic antibody: Correlating structural changes with long-term stability. J Pharm Sci 93 (4): 1005-1018.
406. Costantino HR, Andya JD, Nguyen PA, Dasovich N, Sweeney TD, Shire SJ, Hsu CC, Maa YF. 1998. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J Pharm Sci 87 (11): 1406-1411.
407. Liu WR, Langer R, Klibanov AM. 1990. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotechnol Bioeng 37: 177-184.
408. Costantino HR, Langer R, Klibanov AM. 1995. Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: Effect of moisture and stabilization by excipients. Biotechnology (N Y) 13 (5): 493-496.
409. Hora MS, Rana RK, Wilcox CL, Katre NV, Hirtzer P, Wolfe SN, Thomson JW. 1992. Development of a lyophilized formulation of interleukin-2. Dev Biol Stand 74: 295-303.
410. Chen B, Costantino HR, Liu J, Hsu CC, Shire SJ. 1999. Influence of calcium ions on the structure and stability of recombinant human deoxyribonuclease I in the aqueous and lyophilized states. J Pharm Sci 88 (4): 477-482.
411. Katakam M, Banga AK. 1995. Aggregation of insulin and its prevention by carbohydrate excipients. PDA J Pharm Sci Technol 49 (4): 160-165.
412. Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ. 2001. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res 18 (9): 1345-1353.
413. Andya J, Cleland JL, Hsu CC, Lam XM, Overcashier DE, Shire SJ, Yang JY-F, Wu SS-Y. 2004. Protein Formulation. Genentech, Inc. US6685940 B2.
414. Chang LL, Shepherd D, Sun J, Ouellette D, Grant KL, Tang XC, Pikal MJ. 2005. Mechanism of protein stabilization by sugars during freeze-drying and storage: 204 AGGREGATION OF THERAPEUTIC PROTEINS Native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci 94 (7): 1427-1444.
415. Broersen K, Elshof M, de Groot J, Voragen AGJ, Hamer RJ, de Jongh HHJ. 2007. Aggregation of beta-lactoglobulin regulated by glucosylation. J Agric Food Chem 55 (6): 2431-2437.
416. Schenz TW. 1995. Glass transition and product stability-An overview. Food Hydrocolloids 9: 307-315.
417. Pikal MJ, Rigsbee D, Akers MJ. 2009. Solid state chemistry of proteins IV. What is the meaning of thermal denaturation in freeze dried proteins? J Pharm Sci 98 (4): 1387-1399.
418. Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ. 2001. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res 18 (9): 1345-1353.
419. Maa YF, Nguyen PA, Andya JD, Dasovich N, Hsu CC, et al. 1998. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res 15 (May): 768-775.
420. Ma X, Wang DQ, Bouffard R, MacKenzie A. 2001. Characterization of murine monoclonal antibody to tumor necrosis factor (TNF-MAb) formulation for freeze drying cycle development. Pharm Res 18 (Feb): 196-202.
421. Separovic F, Lam YH, Ke X, Chan HK. 1998. A solid-state NMR study of protein hydration and stability. Pharm Res 15 (12): 1816-1821.
422. Schwendeman SP, Costantino HR, Gupta RK, Tobio M, Chang AC, Alonso MJ, Siber GR, Langer R. 1996. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine. Dev Biol Stand 87: 293-306.
423. Renard D, Lefebvre J, Robert P, Llamas G, Dufour E, Dufour E. 1999. Structural investigation of beta-lactoglobulin gelation in ethanol/water solutions. Int J Biol Macromol 26 (1): 35-44.
424. Maa Y-F, Hsu CC. 1997. Protein denaturation by combined effect of shear and air-liquid interface. Biotechnol Bioeng 54 (6): 503-512.
425. Tsai YR, Yang SJ, Jiang SS, Ko SJ, Hung SH, Kuo SY, Pan RL. 1998. High-pressure effects on vacuolar H +-ATPase from etiolated mung bean seedlings. J Protein Chem 17 (2): 161-172.
426. Tsai PK, Volkin DB, Dabora JM, Thompson KC, Bruner MW, Gress JO, Matuszewska B, Keogan M, Bondi JV, Middaugh CR. 1993. Formulation design of acidic fibroblast growth factor. Pharm Res 10 (5): 649-659.
427. Navarra G, Leone M, Militello V. 2007. Thermal aggregation of beta-lactoglobulin in presence of metal ions. Biophys Chem 131 (13): 52-61.